Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-14
DOI
10.3389/fcvm.2021.750186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study
- (2021) Libo Yu et al. BMC CANCER
- Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
- (2021) Xiaoping Wang et al. MOLECULES
- Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology
- (2021) Wenhao Xu et al. BIOSCIENCE REPORTS
- Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma
- (2021) Brian A. Van Tine et al. CLINICAL CANCER RESEARCH
- Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
- (2021) Yingying Xiao et al. Frontiers in Pharmacology
- TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)
- (2020) Nadine Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
- (2020) Haixia Xu et al. Frontiers in Physiology
- Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
- (2020) Nichanan Osataphan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
- (2020) Jacobus Pfisterer et al. LANCET ONCOLOGY
- Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity
- (2020) Hanan A. Henidi et al. Oxidative Medicine and Cellular Longevity
- Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
- (2020) Lin Li et al. Frontiers in Pharmacology
- Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis
- (2020) Zhong-Yan Zhou et al. Frontiers in Pharmacology
- Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
- (2019) Chowdhury S. Abdullah et al. Scientific Reports
- Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
- (2019) Nadine Wenningmann et al. MOLECULAR PHARMACOLOGY
- Neuroprotective Effects of Red Ginseng Saponins in Scopolamine-Treated Rats and Activity Screening Based on Pharmacokinetics
- (2019) Jianbo Chen et al. MOLECULES
- Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3
- (2019) Liping Meng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
- (2019) Xiaoxue Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways
- (2019) Tian Wei et al. BIOMEDICINE & PHARMACOTHERAPY
- Luteolin ameliorates rat myocardial ischaemia-reperfusion injury through activation of peroxiredoxin II
- (2018) Bo Wei et al. BRITISH JOURNAL OF PHARMACOLOGY
- Microbe-mitochondrion crosstalk and health: An emerging paradigm
- (2018) Prashant Bajpai et al. MITOCHONDRION
- A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
- (2018) Xinyu Yang et al. Frontiers in Pharmacology
- CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
- (2018) Bray Denard et al. BMC CANCER
- Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion
- (2018) Haixia Wang et al. Journal of Ovarian Research
- LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy
- (2017) Yan Xia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Autophagic dysregulation in doxorubicin cardiomyopathy
- (2017) Jordan J. Bartlett et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
- (2016) J. J. Bartlett et al. BIOCHEMICAL JOURNAL
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease
- (2015) Ting-ting Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Isolation of Luteolin and Luteolin-7-O-glucoside from Dendranthema morifolium Ramat Tzvel and Their Pharmacokinetics in Rats
- (2015) Lie-Chwen Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- A Novel Danshensu Derivative Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer Cells
- (2015) Liang Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Continued value of adjuvant anthracyclines as treatment for early breast cancer
- (2015) Natalie Turner et al. LANCET ONCOLOGY
- Breast cancer therapy-associated cardiovascular disease
- (2015) Timothy M. Zagar et al. Nature Reviews Clinical Oncology
- Luteolin from Flos Chrysanthemi and its derivatives: New small molecule Bcl-2 protein inhibitors
- (2014) Can-Hui Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Luteolin inhibits pyrogallol-induced apoptosis through the extracellular signal-regulated kinase signaling pathway
- (2012) Dongxu He et al. FEBS Journal
- Cardioprotective Effects of Luteolin During Ischemia-Reperfusion Injury in Rats
- (2010) Pei-Hu Liao et al. CIRCULATION JOURNAL
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- (2008) Yong Lin et al. CURRENT CANCER DRUG TARGETS
- Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin
- (2008) Günter Seelinger et al. PLANTA MEDICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started